MARKET

FLDM

FLDM

Fluidigm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.29
-0.14
-1.88%
Opening 11:31 08/12 EDT
OPEN
7.53
PREV CLOSE
7.43
HIGH
7.59
LOW
7.22
VOLUME
551.11K
TURNOVER
--
52 WEEK HIGH
9.26
52 WEEK LOW
1.170
MARKET CAP
519.90M
P/E (TTM)
-9.3738
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average FLDM stock price target is 12.67 with a high estimate of 14.00 and a low estimate of 12.00.

EPS

FLDM News

More
UBS Maintains Buy on Fluidigm, Raises Price Target to $12
UBS maintains Fluidigm (NASDAQ:FLDM) with a Buy and raises the price target from $6 to $12.
Benzinga · 1d ago
Fluidigm's (FLDM) CEO Chris Linthwaite on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 4d ago
Fluidigm Corporation 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha - Article · 4d ago
Implied Volatility Surging for Fluidigm (FLDM) Stock Options
Investors need to pay close attention to Fluidigm (FLDM) stock based on the movements in the options market lately.
Zacks · 5d ago
BIIB, GRPN among premarket gainers
Seeking Alpha - Article · 5d ago
Fluidigm EPS beats by $0.07, beats on revenue
Fluidigm (NASDAQ:FLDM): Q2 Non-GAAP EPS of -$0.07 beats by $0.07; GAAP EPS of -$0.18 beats by $0.05. Revenue of $26.06M (-7.6% Y/Y) beats by $6.99M. Press
seekingalpha · 5d ago
Fluidigm Announces Second Quarter 2020 Financial Results
Second Quarter Revenue Decreased 8 Percent to $26.1 Million Filed for FDA Emergency Use Authorization for COVID-19 Saliva-based TestMulti-Site U.S. Study of COVID-19 Patients Utilizes Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay Fluidigm
GlobeNewswire · 5d ago
Fluidigm Reports Distribution Deal With De Novo Software To Provide Customers Access To Data Analysis Solution For High-Parameter Data Files, No Terms Disclosed
Benzinga · 08/04 12:31

Industry

Advanced Medical Equipment & Technology
+1.78%
Healthcare Equipment & Supplies
+1.71%

Hot Stocks

Symbol
Price
%Change

About FLDM

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.
More

Webull offers kinds of Fluidigm Corporation stock information, including NASDAQ:FLDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLDM stock methods without spending real money on the virtual paper trading platform.